Ocular Therapeutix (OCUL) Announces Board and Leadership Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Ocular Therapeutix™ Announces Board of Directors and Leadership Updates
February 22, 2024 7:30 AM ESTIndustry Leader and Retina Expert, Pravin U. Dugel, MD, Becomes Executive Chair
Jeffrey S. Heier, MD to become Chief Scientific Officer, Peter K. Kaiser, MD to be Medical Director, and Sanjay Nayak, MBBS, PhD to become Chief Strategy Officer
Addition of Strategic and Clinical Experts Puts Ocular on Track to be a Leader in Retina Care
Expanded Team Anticipated to Accelerate Momentum in AXPAXLI Phase 3 Wet AMD Programs
BEDFORD, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, Ocular), a... More
